More bad news for psychedelic drug company: FDA expands probe after rejection
Psychedelic drug company Lykos already slashed staff and overhauled leadership.
-
Read more: More bad news for psychedelic drug company: FDA expands probe after rejection -
diamond shruumz, hallucinogenic, health, muscimol, mushroom, poison, psilocin, psilocybin, psychedelics, Science, Tech Industry, Tech NewsIllegal drug found in Diamond Shruumz candies linked to severe illnesses
Read more: Illegal drug found in Diamond Shruumz candies linked to severe illnessesNew testing finds psilocin, related to psilocybin, in gummies purchased in 2023.
-
cases, diamond shruumz, health, microdosing, muscimol, Mushrooms, psychedelics, Science, seizures, Tech Industry, Tech News, toxicology
What we know about microdosing candy illnesses as death investigation underway
Read more: What we know about microdosing candy illnesses as death investigation underwayMedical toxicologist walks through what we know and don’t know about the cases.
-
The nature of consciousness, and how to enjoy it while you can
Read more: The nature of consciousness, and how to enjoy it while you canIn his new book, Christof Koch views consciousness as a theorist and an aficionado.
-
MDMA—aka ecstasy—submitted to FDA as part of PTSD therapy
Read more: MDMA—aka ecstasy—submitted to FDA as part of PTSD therapyIf FDA approved, it would require the DEA to reclassify MDMA.
-
Psychedelics plus psychotherapy can trigger rapid changes in the brain
Read more: Psychedelics plus psychotherapy can trigger rapid changes in the brainResearch delves into how the brain facilitates accelerated change.
-
biotech, EC Healthtech, EC investor survey, mental health, psychedelics, Startups, Tech Industry, Venture
11 investors predict a colorful, if difficult, future for psychedelic startups
Read more: 11 investors predict a colorful, if difficult, future for psychedelic startupsHow far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look. 11 investors predict a colorful, if difficult, future for psychedelic startups by Anna Heim originally published on TechCrunch
-
biochemistry, Biology, hallucinogens, LSD, neurobiology, psychedelics, Science, Tech Industry, Tech News
New mechanism proposed for why some psychedelics act as antidepressants
Read more: New mechanism proposed for why some psychedelics act as antidepressantsWe know what receptors they bind, but where they bind them might matter, too.
